Company / Interest Expense
Veracyte, Inc. Interest Expense History
FY2016-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.0M
FY2020
5-year range
-
FY2016-FY2020
Trend
+190.0%
vs FY2019
Sector context
#41 of 44
Health Care
What the data says
Among 44 Health Care companies, Veracyte, Inc. is in the top 7% for interest expense. Interest Expense has fluctuated over the past 5 years, ranging from $378,000 in FY2017 to $2M in FY2020.
Based on SEC 10-K filings.
$2M in FY2020 with a 3-year CAGR of +73.2%.
Remained stable around $2M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +73.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 44This company $2.0M Sector average $316.9M
▼
-99.4% below sector average
Key checks
Key Insights
- 3-year CAGR of +73.2%, indicating consistent growth.
- In FY2020, interest expense increased 190.0% year-over-year.
- Ranks #41 out of 44 companies in the Health Care sector.
- Lowest interest expense in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $2.0M | +190.0% |
| FY2019 | $677.0K | -65.5% |
| FY2018 | $2.0M | +419.3% |
| FY2017 | $378.0K | -13.9% |
| FY2016 | $439.0K | +16.1% |
As of FY2020 · SEC 10-K · Updated Jun 30, 2026